Adoptive immunotherapy in the treatment of malignant disease

Transfusion. 1989 Feb;29(2):170-8. doi: 10.1046/j.1537-2995.1989.29289146838.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Humans
  • Immunotherapy / adverse effects
  • Immunotherapy / methods*
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / adverse effects
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / transplantation
  • Lymphocytosis / chemically induced
  • Mice
  • Monocytes / drug effects
  • Monocytes / immunology
  • Monocytes / transplantation
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Rats
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / adverse effects
  • Recombinant Proteins / pharmacology
  • Remission Induction
  • T-Lymphocytes / immunology
  • T-Lymphocytes / transplantation

Substances

  • Interleukin-2
  • Recombinant Proteins